Wall Street Brief: Samsung STANDS UP Against Apple, Ford CHALLENGED in Europe
Samsung (SSNLF.PK) has responded to Apple’s (NASDAQ:AAPL) request to ban the U.S sales of eight phones by saying it “will take all necessary measures to ensure the availability of our products in the...
View ArticleHealthcare Business Review: Express Script Suit DISMISSED, Covidien WINS FDA...
Chief Operations Officer Pascal Soriot of Roche Holding Ltd. (RHHBY.OB) has been chosen by AstraZeneca Group plc (NYSE:AZN) to be its new chief executive, to replace David Brennan, who stepped down on...
View ArticleThis FDA Scandal May Harm Drug Stocks
An article to be published Wednesday in the Journal of the American Medical Association makes clear that the Food and Drug Administration has allowed drugs for stroke prevention, cancer, and multiple...
View ArticleHealthcare Biz Recap: Pluristem Shares SURGE, Amarin Gets New PATENTS
Stem-cell treatment company Pluristem Therapeutics, Inc. (NASDAQ:PSTI) shares take off subsequent to word that a third critically ill patient received treatment with its med and that the “outcome of...
View ArticleHealthcare Business Recap: Santarus’s Good NEWS, AstraZeneca Issues BONDS
Santarus, Inc. (NASDAQ:SNTS) reports that an advanced evaluation of its investigational antibiotic Rifamycin SV MMX met its primary endpoint in the treatment of travelers’ diarrhea. In response, Stifel...
View ArticleMasterCard Affected by Processing Decline and 1 Morning Hot Stocks Not to...
MasterCard (NYSE:MA) cites a decline in global transaction processing and currency headwinds as the reasons for slower growth in revenues in the second-half compared to what was witnessed in Q2. The...
View ArticleHealthcare Business Recap: Top Pharmas Form Non-Profit TransCelerate
These were Thursday’s top stories: Ten top pharmaceutical companies, including Johnson & Johnson (NYSE:JNJ), Eli Lilly and Company (NYSE:LLY), AstraZeneca Group plc (NYSE:AZN), GlaxoSmithKline...
View ArticleHealthcare Business Recap: Questcor Faces Inquiry, AstraZeneca Data Published
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has bought the rights to Visudyne, which is a treatment for a form of age-related blindness in which there is an abnormal growth of leaky blood...
View ArticleHealthcare Business Roundup: Depomed Sues the FDA, Abbott Gets Orphan...
Depomed, Inc. (NASDAQ:DEPO) brings a suit in a Washington, D.C. federal court, seeking an order to require that the FDA grant market exclusivity for Gralise, its medication for post-herpetic neuralgia,...
View ArticleAstraZeneca’s New Strategy
Pharmaceutical manufacturer AstraZeneca (NYSE:AZN) announced Monday that it would suspend share buybacks as the board and new Chief Executive Officer Pascal Soriot review the company’s strategy....
View Article
